Skip to main content

Advertisement

Log in

Exploring Nocardia’s ecological spectrum and novel therapeutic frontiers through whole-genome sequencing: unraveling drug resistance and virulence factors

  • Original Paper
  • Published:
Archives of Microbiology Aims and scope Submit manuscript

Abstract

Nocardia farcinica is the leading pathogen responsible for nocardiosis, a life-threatening infection primarily affecting immunocompromised patients. In this study, the genomic sequence of a clinically isolated N. farcinica sample was sequenced. Subsequently, the assembled genome was annotated to identify antimicrobial resistance and virulence genes, as well as plasmid and prophages. The analysis of the entire genome size was 6,021,225 bp, with a GC content of 70.78% and consists of 103 contigs and N50 values of 292,531 bp. The genome analysis revealed the presence of several antimicrobial resistance genes, including RbpA, mtrA, FAR-1, blaFAR-1, blaFAR-1_1, and rox. In addition, virulence genes such as relA, icl, and mbtH were also detected. The present study signifies that N. farcinica genome is pivotal for the understanding of antimicrobial resistance and virulence genes is crucial for comprehending resistance mechanism, and developing effective strategies to combat bacterial infections effectively, especially adhesins and toxins. This study aids in identifying crucial drug targets for combating multidrug-resistant N. farcinica in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17

Similar content being viewed by others

Data availability

We deposited at the NCBI databases raw reads under the SRA are SRX17912461. The associated bioproject and biosample accession numbers are PRJNA890792 and SAMN31293886.

References

Download references

Funding

The author thank MHRD—RUSA 2.0, New Delhi (F.24e51/2014-U), TANSCHE (RGP/2019-20/ALU/HECP-0049 dated: 27/04/2021), DST-INDO-TAIWAN (GITA/DST/TWN/P-86/2019), Department of Biotechnology Bioinformatics Centre (BIC)-No. BT/PR40154/BTIS/137/34/2021, DBT-NNP-N0.BT/PR40156/BTIS/137/54/2023, DST-Fund for Improvement of S&T Infrastructure in Universities & Higher Educational Institutions (FIST) (SR/FST/LSI-667/2016) (C), and DST-Promotion of University Research and Scientific Excellence (PURSE phase II) (No. SR/PURSE Phase 2/38(G), 2017), NH greatly acknowledges the Department of Science and Technology (DST), for financial assistance through DST/INSPIRE Fellowship/2019/IF190083. Policy (TNMulti-Gen). RR thankfully acknowledges the Indian Council of Medical Research [AMR/Fellowship/24/2022-ECD-II] for a Senior Research Fellowship. MA sincerely acknowledges the Indian Council of Medical Research, New Delhi for providing financial assistance through Research Associate (AMR/Fellowship/39/2022-ECD-II).

Author information

Authors and Affiliations

Authors

Contributions

SN: Conceptualizations, data curation, formal analysis, visualization, writing—original draft, writing—review and editing, RR: Conceptualizations and data curation, NH: writing—review and editing, AM: AST analysis, JJ: Conceptualizations, methodology, supervision, funding acquisition, writing—review and editing, CJ and JDK: resources, sample collection, and sequencing.

Corresponding author

Correspondence to Jeyakanthan Jeyaraman.

Ethics declarations

Conflict of interests

There is no conflict of interest.

Additional information

Communicated by Yusuf Akhter.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 287 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nathar, S., Rajmichael, R., Jeyaraj Pandian, C. et al. Exploring Nocardia’s ecological spectrum and novel therapeutic frontiers through whole-genome sequencing: unraveling drug resistance and virulence factors. Arch Microbiol 206, 76 (2024). https://doi.org/10.1007/s00203-023-03799-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00203-023-03799-z

Keywords

Navigation